OXYTROL (Allergan, Inc.)


Welcome to the PulseAid listing for the OXYTROL drug offered from Allergan, Inc.. This Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Allergan, Inc.
NON-PROPRIETARY NAME: Oxybutynin
SUBSTANCE NAME: OXYBUTYNIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]
ROUTE: TRANSDERMAL
DOSAGE FORM: PATCH
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2003-02-26
END MARKETING DATE: 0000-00-00


OXYTROL HUMAN PRESCRIPTION DRUG Details:

Item DescriptionOXYTROL from Allergan, Inc.
LABELER NAME: Allergan, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 3.9(mg/d)
START MARKETING DATE: 2003-02-26
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0023-6153_f36f3819-927f-4ec6-a42e-333af9a6907a
PRODUCT NDC: 0023-6153
APPLICATION NUMBER: NDA021351

Other OXYBUTYNIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Gelnique
Allergan, Inc.OXYTROL